WA
AXSM icon

WPG Advisers’s Axsome Therapeutics AXSM Stock Holding History

WPG Advisers’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1K Sell
60
-18
-23% -$3.11K 0.01% 667
2025
Q4 		$14.2K Buy
78
+8
+11% +$1.12K 0.01% 599
2025
Q3 		$8.5K Buy
70
+1
+1% +$113 0.01% 744
2025
Q2 		$7.2K Buy
69
+8
+13% +$847 0.01% 756
2025
Q1 		$7.11K Buy
61
+21
+53% +$2.39K 0.01% 752
2024
Q4 		$3.38K Buy
+40
New +$3.68K ﹤0.01% 937

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WPG Advisers's AXSM Position: Q1 2026 in Review

WPG Advisers reduced its Axsome Therapeutics (AXSM) stake by 23% in Q1 2026, selling an estimated $3.11K and leaving 60 shares worth $10.1K. The position accounts for 0.01% of the portfolio, ranked #667.

WPG Advisers first reported a position in AXSM in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.2K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • WPG Advisers held 60 shares of Axsome Therapeutics worth $10.1K as of Q1 2026.
  • WPG Advisers sold 18 Axsome Therapeutics shares in Q1 2026, an estimated $3.11K.
  • Axsome Therapeutics made up 0.01% of WPG Advisers's portfolio in Q1 2026, its #667 holding.
  • WPG Advisers first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • WPG Advisers's Axsome Therapeutics position peaked at $14.2K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.